Evidence map›Paper›PMID 32164540›Full record

ArticleBMC bioinformatics2020

Robust pathway sampling in phenotype prediction. Application to triple negative breast cancer.

Ana Cernea, Juan Luis Fernández-Martínez, Enrique J deAndrés-Galiana, Francisco Javier Fernández-Ovies, Oscar Alvarez-Machancoses, Zulima Fernández-Muñiz, Leorey N Saligan, Stephen T Sonis

Abstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana CerneaGroup of Inverse Problems, Optimization and Machine Learning, Department of Mathematics, University of Oviedo, C/ Federico García-Lorca, 18, 33007, Oviedo, Spain.
Juan Luis Fernández-MartínezGroup of Inverse Problems, Optimization and Machine Learning, Department of Mathematics, University of Oviedo, C/ Federico García-Lorca, 18, 33007, Oviedo, Spain. jlfm@uniovi.es.
Enrique J deAndrés-GalianaGroup of Inverse Problems, Optimization and Machine Learning, Department of Mathematics, University of Oviedo, C/ Federico García-Lorca, 18, 33007, Oviedo, Spain.
Francisco Javier Fernández-OviesGroup of Inverse Problems, Optimization and Machine Learning, Department of Mathematics, University of Oviedo, C/ Federico García-Lorca, 18, 33007, Oviedo, Spain.
Oscar Alvarez-MachancosesGroup of Inverse Problems, Optimization and Machine Learning, Department of Mathematics, University of Oviedo, C/ Federico García-Lorca, 18, 33007, Oviedo, Spain.
Zulima Fernández-MuñizGroup of Inverse Problems, Optimization and Machine Learning, Department of Mathematics, University of Oviedo, C/ Federico García-Lorca, 18, 33007, Oviedo, Spain.
Leorey N SaliganNational Institutes of Health, National Institute of Nursing Research, Bethesda, MD, USA.
Stephen T SonisPrimary Endpoint Solutions, Watertown, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPhenotype prediction problems are usually considered ill-posed, as the amount of samples is very limited with respect to the scrutinized genetic probes. This fact complicates the sampling of the defective genetic pathways due to the high number of possible discriminatory genetic networks involved. In this research, we outline three novel sampling algorithms utilized to identify, classify and characterize the defective pathways in phenotype prediction problems, such as the Fisher's ratio sampler, the Holdout sampler and the Random sampler, and apply each one to the analysis of genetic pathways involved in tumor behavior and outcomes of triple negative breast cancers (TNBC). Altered biological pathways are identified using the most frequently sampled genes and are compared to those obtained via Bayesian Networks (BNs).

resultsRandom, Fisher's ratio and Holdout samplers were more accurate and robust than BNs, while providing comparable insights about disease genomics.

conclusionsThe three samplers tested are good alternatives to Bayesian Networks since they are less computationally demanding algorithms. Importantly, this analysis confirms the concept of "biological invariance" since the altered pathways should be independent of the sampling methodology and the classifier used for their inference. Nevertheless, still some modifications are needed in the Bayesian networks to be able to sample correctly the uncertainty space in phenotype prediction problems, since the probabilistic parameterization of the uncertainty space is not unique and the use of the optimum network might falsify the pathways analysis.

Indexed as

AlgorithmsBayes TheoremDatabases, GeneticFemaleGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansNeoplasm MetastasisPhenotypeSurvival AnalysisTriple Negative Breast Neoplasms

Identifiers

PMID32164540
PMCPMC7068866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.